Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of Recurrent Vulvovaginal Candidiasis.

Jack D. Sobel1

  • 1Division of Infectious Diseases, Harper University Hospital, 3990 John R - Room 4811, Detroit, MI 48201, USA. jsobel@intmed.wayne.edu

Current Infectious Disease Reports
|November 16, 2002
PubMed
Summary

Recurrent vulvovaginal candidiasis (RVVC) presents significant challenges. Many cases lack identifiable causes, suggesting an immune system role in this common condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estrogen Replacement Therapy to Prevent Recurrent Urinary Tract Infection in Postmenopausal Women.

Current infectious disease reports·2003
Same author

Antibiotic-associated Vulvovaginal Candidiasis.

Current infectious disease reports·2003
Same author

Erosive Vulvovaginitis.

Current infectious disease reports·2003
Same author

Treatment of vulvovaginal lichen planus with vaginal hydrocortisone suppositories.

Current infectious disease reports·2002
Same author

Clinical Trials Report.

Current infectious disease reports·2001
Same author

Antimicrobial Resistance in Vulvovaginitis.

Current infectious disease reports·2001

Area of Science:

  • Gynecology
  • Infectious Diseases
  • Immunology

Background:

  • Recurrent vulvovaginal candidiasis (RVVC) is a prevalent condition causing significant patient distress and posing therapeutic difficulties.
  • The etiology of RVVC is multifactorial, necessitating comprehensive management strategies that address complex causative pathways.
  • While progress has been made in identifying secondary causes, including biologic and host factors, a substantial portion of RVVC cases remain unexplained.

Purpose of the Study:

  • To explore the multifactorial etiology of recurrent vulvovaginal candidiasis (RVVC).
  • To investigate potential host and microbial factors contributing to RVVC.
  • To generate hypotheses regarding the role of the immune system in RVVC pathogenesis.

Main Methods:

  • Review of existing literature on RVVC etiology.
  • Analysis of microbiologic data regarding Candida species and azole resistance.
  • Evaluation of identified host and microbial predisposing factors.

Main Results:

  • Azole resistance in Candida albicans is infrequent.
  • Infection by non-albicans Candida species with reduced sensitivity is uncommon.
  • At least 50% of women with RVVC lack identifiable predisposing host or microbial factors.

Conclusions:

  • The multifactorial nature of RVVC requires consideration of complex etiologic pathways.
  • Identified microbial factors like azole resistance are not the primary drivers in most RVVC cases.
  • The high prevalence of unexplained cases supports an immune-based hypothesis for RVVC pathogenesis.

Related Experiment Videos